NFG
ARCT icon

Next Financial Group’s Arcturus Therapeutics ARCT Stock Holding History

Next Financial Group’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14
Closed -$86 – 1946
2018
Q3 		$0 Buy
+14
New +$117 ﹤0.01% 1460
2017
Q4 		– Sell
-14
Closed – – 329
2017
Q3 		$0 Hold
14
– – ﹤0.01% 1746
2017
Q2 		$0 Buy
+14
New +$113 ﹤0.01% 1898
2017
Q1 		– Sell
-14
Closed – – 1883
2016
Q4 		$0 Hold
14
– – ﹤0.01% 2372
2016
Q3 		$0 Hold
14
– – ﹤0.01% 2362
2016
Q2 		$0 Hold
14
– – ﹤0.01% 1734
2016
Q1 		$0 Hold
14
– – ﹤0.01% 1719
2015
Q4 		$0 Hold
14
– – ﹤0.01% 1771
2015
Q3 		$0 Hold
14
– – ﹤0.01% 1812
2015
Q2 		$0 Hold
14
– – ﹤0.01% 1838
2015
Q1 		$0 Hold
14
– – ﹤0.01% 1840
2014
Q4 		$0 Hold
14
– – ﹤0.01% 1905
2014
Q3 		$2K Buy
14
+7
+100% +$912 ﹤0.01% 2285
2014
Q2 		$1K Buy
+7
New +$845 ﹤0.01% 1119

Other funds holding ARCT

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Next Financial Group's ARCT Position: Q4 2018 in Review

Next Financial Group sold out of Arcturus Therapeutics (ARCT) in Q4 2018, closing a stake of 14 shares — an estimated $86 sold.

Next Financial Group first reported a position in ARCT in Q2 2014 and held it in 14 quarters. The position peaked at $2K in Q3 2014. 19 funds tracked by Wall St. Rank hold ARCT as of Q4 2018.

  • Next Financial Group reported no remaining Arcturus Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Next Financial Group sold 14 Arcturus Therapeutics shares in Q4 2018, an estimated $86.
  • Next Financial Group first reported a position in Arcturus Therapeutics in Q2 2014 and held it in 14 quarters.
  • Next Financial Group's Arcturus Therapeutics position peaked at $2K in Q3 2014.
  • 19 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2018.

Based on Next Financial Group's 13F filing for Q4 2018, filed 11 Feb 2019.